An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
Clinical trial NCT05669794 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05669794
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-21
- Primary completion
- 2027-02-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.